You may also view these results as a <a href="https://ceirr-public-website-static-prod.s3.amazonaws.com/H5N1_CVV+testing_Final.pdf" target="_blank" rel="noopener noreferrer" download="download">PDF version</a>.<hr>Please Note: This data was shared with the relevant U.S. federal government agencies responsible for wider testing, surveillance, and response efforts associated with the H5N1 outbreak in U.S. dairy cattle.

H5N8 IIV-like vaccine cross-reactive antibody results against A/bovine H5N1.

large_H5N1_CVV-testing_Final.png

medium_H5N1_CVV-testing_Final.png

small_H5N1_CVV-testing_Final.png

thumbnail_H5N1_CVV-testing_Final.png

H5N1_CVV-testing_Final.png

Bovine H5N1 Outbreak

Influenza

SJCEIRR

Outbreaks

Vaccine

SJCEIRR researchers found that an inactivated influenza A/H5N8-like vaccine elicits cross-reactive antibodies to an influenza A/bovine H5N1 strain from the recent outbreak.

sj_logo.png

NIAID Monovalent Inactivated Influenza A/H5N8 Clinical Trials

NIAID Monovalent Inactivated Influenza A/H5N8 Clinical Trials

Cross-reactive Hemagglutination Inhibition (HAI) Antibodies to Emerging Strains